Empresa Satsuma Pharmaceuticals, Inc.
Acciones
STSA
US80405P1075
Biotecnología e investigación médica
Resumen de negocios
Número de empleados: 25
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Mic Iwashima
COO | Chief Operating Officer | 46 | 01/01/17 |
Chief Tech/Sci/R&D Officer | 63 | 01/07/17 | |
Shannon Strom
LAW | General Counsel | 48 | 01/05/18 |
Corporate Officer/Principal | - | 05/03/20 | |
Robert Schultz
PRN | Corporate Officer/Principal | 60 | 01/07/17 |
Shinji Nitanda
SEC | Corporate Secretary | 55 | 08/06/23 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Ryoichi Nagata
CEO | Chief Executive Officer | 65 | 08/06/23 |
Director/Board Member | 64 | 08/06/23 | |
Ken Takanashi
BRD | Director/Board Member | 59 | 01/06/16 |
Shunji Haruta
BRD | Director/Board Member | - | 08/06/23 |
Akihisa Mori
BRD | Director/Board Member | - | 08/06/23 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 33 152 498 | 27 782 705 ( 83,80 %) | 0 | 83,80 % |
Información de la empresa
Satsuma Pharmaceuticals, Inc.
4819 Emperor Boulevard Suite 340
27703, Durham
+650 410 3200
http://www.satsumarx.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-2,31 % | 103 mil M | |
+0,56 % | 95,28 mil M | |
+1,69 % | 22,15 mil M | |
-17,37 % | 21,02 mil M | |
-9,30 % | 18,15 mil M | |
-41,01 % | 16,74 mil M | |
-14,85 % | 16,05 mil M | |
+3,21 % | 13,68 mil M | |
+33,54 % | 12,17 mil M |